Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.
about
Oral anti-pseudomonal antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisMeasuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical reviewState of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?Oral anti-pseudomonal antibiotics for cystic fibrosisFrom Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials.Exacerbations in cystic fibrosis: 2 . prevention.Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adults.Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetesMolecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilmsMechanisms of action and clinical application of macrolides as immunomodulatory medications.Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis.Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.Pseudomonal infection in cystic fibrosis: the battle continues.Long-term macrolide therapy in chronic obstructive pulmonary disease.Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilmAntibiotic allergy in cystic fibrosis.Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosisAzithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice.Optimal management of severe/refractory asthma.Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.How has research in the last five years changed my clinical practice?Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease.Macrolides in cystic fibrosis: is there a role?Macrolide antibiotics: current and future uses.Inflammatory markers of lung disease in adult patients with cystic fibrosis.Azithromycin for improving pulmonary function in cystic fibrosis.Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot studyThe role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.Macrolide antibiotics and survival in patients with acute lung injury.Use of macrolides and tetracyclines for chronic inflammatory diseases.Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics
P2860
Q24202879-24E8F17C-11A0-434A-8601-11FC9A7A58E1Q24202885-438F94D2-48EB-4DEE-87FF-9992B17D0071Q24234430-006670AA-44F2-490D-B2CD-502273C4BB64Q24243916-EB2E86DE-87CB-4536-92E9-9B705883630FQ24247243-8A3C2685-7856-494B-B648-028D08BC40AFQ24250150-F4409E47-61A0-48FF-B297-9DFC9CCC07DAQ24795582-FE323F16-BF5A-4EAB-B57A-5868413459DAQ24802489-F68E2B13-A6AB-49F6-AB54-2A1110DE0722Q26471106-6D4D16D9-9D99-4B57-9452-D016F4DD27BAQ27687259-57CA24A9-DF92-4E2E-A401-557CF26405DDQ30480308-EAFABE9B-90F5-4CEF-8AC0-F9D6470C0BF1Q33689718-E66B1C84-58F4-4AF0-B6CC-44969A9B2459Q33858854-3D1B30E5-B211-4AEA-B7E4-052804D09AB7Q33935451-31AA6A8D-8A8D-4486-BFB7-F396F66D9464Q33983140-54929A25-C388-4249-A0C4-863F9B9A6079Q34017297-DFF94EE4-5425-4CD8-BAD6-8EE8753ED566Q34073568-3C58FEF7-6B44-48FB-8BC7-8A461BEC005FQ34078696-3ED90318-C41A-40E8-8698-287587842E20Q34358536-DBE1CAC3-7569-4644-AB18-EDBB50232786Q34373310-CEB789C5-C163-43E6-B1FF-A3FCF918F043Q34375192-CDB631F9-A4E9-4437-8BE9-777E5F028309Q34408724-8B220358-BFC7-4595-8971-8D7B78A22874Q34558027-3534A7A5-F607-4268-A8C1-C0A84556F138Q34675784-955949E2-AA56-4A33-A69D-2CA9E6A3BE1EQ35088797-6F43A059-0578-44A9-B29F-AACACF772933Q35132254-792C5F39-7DD5-40DC-B994-26F0B89508DBQ35193179-F88C215A-D02C-4FEA-9474-D73C769768C0Q35223657-47950CF7-61E2-4F15-BAF4-657340FDDE2BQ35284521-D6A0422C-F9CE-4B87-93E0-8B3E8B115DFFQ35557381-DB089F31-DC99-40B6-A57B-17E1D3382C25Q35609105-908C5003-2B6C-40D7-B368-230B9F8E7879Q35627801-641F82AF-3283-4B22-86AA-021C3CAB788FQ35688156-CFBA0E27-6A94-4CFD-A6A9-B84176561A6DQ35749974-AD0DD956-0AAE-448B-A60C-68DAA941E9A0Q35814856-1D08B2D7-3F1D-43B5-867C-0B7528D371EEQ35850824-E7B97A6C-8799-4CF1-8E19-F897D3B7D7C3Q35917015-830FA2B5-1547-421F-B2AF-9EA4C1702495Q35929943-30A08EE2-AC5F-4D6B-9BCC-924E2A5D4AABQ35962028-0C6CECC7-EC98-4329-A3C4-39686F971827Q36072425-6EB0586A-34CF-459F-8062-B50BC7F3E527
P2860
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of long term treatment ...... fibrosis: a randomised trial.
@ast
Effect of long term treatment ...... fibrosis: a randomised trial.
@en
type
label
Effect of long term treatment ...... fibrosis: a randomised trial.
@ast
Effect of long term treatment ...... fibrosis: a randomised trial.
@en
prefLabel
Effect of long term treatment ...... fibrosis: a randomised trial.
@ast
Effect of long term treatment ...... fibrosis: a randomised trial.
@en
P2093
P2860
P356
P1433
P1476
Effect of long term treatment ...... c fibrosis: a randomised trial
@en
P2093
P2860
P304
P356
10.1136/THORAX.57.3.212
P407
P577
2002-03-01T00:00:00Z